Results 31 to 40 of about 116,470 (287)
Clostridium difficile causes a million of illnesses each year worldwide and can affect people of all ages. Limited data exist on the prevalence of C. difficile infections (CDI) among children below five years of age in developing countries. This study is
Mwanaisha Seugendo +7 more
doaj +1 more source
Dietary-based gut flora modulation against Clostridium difficile onset [PDF]
Clostridium difficile infection is a frequent complication of antibiotic therapy in hospitalised patients, which today is attracting more attention than ever and has led to its classification as a 'superbug'.
Gibson, G.R. +2 more
core +1 more source
Clostridium difficile merupakan flora normal dalam saluran pencernaan manusia, tetapi dalam keadaan tertentu dapat menimbulkan penyakit, yaitu menjadi patogen bila ada kesempatan untuk bermultiplikasi dan membentuk toksin.
Dwi Prasetyo
doaj +1 more source
Background Hospitalization and antibiotic treatment can put patients at high risk for Clostridium difficile infection, where a disturbance of the gut microbiome allows for Clostridium difficile proliferation and associated symptoms, including mild ...
Maureen Hitschfeld +8 more
doaj +1 more source
Risk factors for infection in HIV-infected patients
Background: Clostridium difficile infection is a healthcare-associated infection resulting in significant morbidity. Although immunosuppression is associated with Clostridium difficile infection acquisition and adverse outcomes, the epidemiology of ...
Hannah Imlay, Daniel Kaul, Krishna Rao
doaj +1 more source
Polyclonal Antibody Therapies for Clostridium difficile Infection
Clostridium difficile infection has emerged as a growing worldwide health problem. The colitis of Clostridium difficile infection results from the synergistic action of C. difficile secreted toxins A and B upon the colon mucosa.
Michael R. Simon +2 more
doaj +1 more source
Diarrhea associated with Clostridium difficile in the oncology clinic
Purpose of the study. To conduct typing of toxigenic strains of Clostridium difficile, obtained from oncological patients who are in hospital.Material and Methods. The study included 130 patients with Clostridium difficile – associated diarrhea.
I. A. Klyuchnikova +6 more
doaj +1 more source
High sporulation and overexpression of virulence factors in biofilms and reduced susceptibility to vancomycin and linezolid in recurrent Clostridium [Clostridioides] difficile infection isolates [PDF]
Clostridium [Clostridioides] difficile infection (CDI) is one of the leading causes of diarrhea associated with medical care worldwide, and up to 60% of patients with CDI can develop a recurrent infection (R-CDI). A multi-species microbiota biofilm model
Baines, Simon +9 more
core +2 more sources
Clostridium difficile – still a problem among the XXI century in case of geriatic patient
Introduction. The disease caused by Clostridium difficile (CzcD - Clostridium difficile -associated disease) - was defined by the Centres for Disease Control and Prevention in Atlanta in 2007 in order to standardize monitoring conditions of diarrhea ...
Agnieszka Ulatowska +7 more
doaj +1 more source
Lauric acid is an inhibitor of Clostridium difficile growth in vitro and reduces inflammation in a mouse infection model [PDF]
Indexación: Scopus.Clostridium difficile is a Gram-positive, spore-forming anaerobic human gastrointestinal pathogen. C. difficile infection (CDI) is a major health concern worldwide, with symptoms ranging from diarrhea to pseudomembranous colitis, toxic
Ababouch +71 more
core +1 more source

